Literature DB >> 25086674

The expression levels and prognostic value of high temperature required A2 (HtrA2) in NSCLC.

Guoxin Mao1, Liting Lv1, Yifei Liu2, Buyou Chen1, Mei Li1, Tingting Ni1, Dunpeng Yang3, Hongzhen Zhu1, Qun Xue4, Runzhou Ni5.   

Abstract

High temperature required A2 (HtrA2) is a serine kinase that is released from mitochondria into the cytosol upon apoptotic stimuli, inducing apoptosis in various cancers. Thus, analysis of the expression of HtrA2 in non-small-cell lung cancer (NSCLC) tissues is needed for the understanding of this malignancy. In this study we firstly analyzed the apoptosis effect of HtrA2 in A549 cells by RNA interference and cisplatin with Western blot and flow cytometry. Then HtrA2 expression was evaluated by Western blot and immunohistochemistry in NSCLC tissues. Western blot and flow cytometry analyses indicated that deletion of HtrA2 was negatively correlated with apoptosis-induced protein in A549 cells. HtrA2 was lowly expressed in NSCLC and significantly associated with histological differentiation and clinical stage. Besides, low expression of HtrA2 was a prognostic factor for NSCLC patients' inferior survival. In conclusion, HtrA2 might promote the apoptosis of NSCLC cells, and serve as a target for NSCLC's treatment.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; HtrA2; Non-small-cell lung cancer; Prognosis

Mesh:

Substances:

Year:  2014        PMID: 25086674     DOI: 10.1016/j.prp.2014.06.030

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Authors:  Hiroaki Soyama; Morikazu Miyamoto; Masashi Takano; Tadashi Aoyama; Hiroko Matsuura; Takahiro Sakamoto; Kazuki Takasaki; Mika Kuwahara; Kento Kato; Tomoyuki Yoshikawa; Hideki Iwahashi; Hitoshi Tsuda; Kenichi Furuya
Journal:  Med Oncol       Date:  2017-11-22       Impact factor: 3.064

2.  The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma.

Authors:  Honggang Wang; Fuguo Jiang; Furong Hao; Ruixue Ju
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

3.  mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer.

Authors:  Liangliang Wu; Xiao Li; Xin Chen; Fan Wu; Guangshun Sun; Ye Cheng; Weiwei Tang; Wenling Zhang; Chengyu Lv
Journal:  J Clin Lab Anal       Date:  2021-10-28       Impact factor: 2.352

4.  Expression of HTRA Genes and Its Association with Microsatellite Instability and Survival of Patients with Colorectal Cancer.

Authors:  Dorota Zurawa-Janicka; Jarek Kobiela; Tomasz Slebioda; Rafal Peksa; Marcin Stanislawowski; Piotr Mieczyslaw Wierzbicki; Tomasz Wenta; Barbara Lipinska; Zbigniew Kmiec; Wojciech Biernat; Andrzej Jacek Lachinski; Zbigniew Sledzinski
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.